Merz Aesthetics
Merz Aesthetics is the company behind a portfolio of aesthetic brands. A company name does not describe one particular procedure. The product or device name helps you understand which treatment is being discussed.
Curated brands · Collagen support & ultrasound
A familiar brand name is a useful starting point. Understanding what that treatment actually does is the next step. Radiesse and Ultherapy belong to the Merz Aesthetics portfolio and offer different approaches to facial support and skin firmness.
At London Finsbury Clinic in King’s Cross, your consultation connects the product or technology with the change you would like to see. We explain the treatment, coverage, comfort measures and current price in a clear, personal conversation.
Explore RadiesseExplore Ultherapy →
Merz Aesthetics is the company behind a portfolio of aesthetic brands. A company name does not describe one particular procedure. The product or device name helps you understand which treatment is being discussed.
Radiesse is an injectable calcium hydroxylapatite product. It can be used in plans for facial support, contour and collagen stimulation. The area, formulation and treatment approach depend on the purpose your doctor explains.
Ultherapy is an ultrasound device treatment, rather than an injectable product. It has a different role in a plan for skin lifting and firmness. Our treatment page explains the clinic’s available areas and appointment options.
Facial volume, skin firmness, hydration and surface texture are different concerns. Someone noticing a change in cheek support may need a different conversation from someone mainly interested in skin tightening. We consider your facial features, previous procedures and preferred finish together, then explain the options that fit.
Radiesse is also different from a hyaluronic acid filler such as Juvéderm. Juvelook and Lenisna (Juvelook Volume) belong to another collagen-stimulator family. Keeping these names clear makes comparing treatments and planning future appointments easier.
Know the name of the product or device and what it is intended to address in your plan. Ask about the proposed areas and why that approach has been recommended for your skin and features.
For an injectable treatment, discuss the quantity and area. For a device appointment, discuss the coverage and treatment allocation. Compare the complete appointment, rather than a headline price alone.
Tell us about previous sensitivity or discomfort. We explain suitable comfort support, check your feedback and give you practical aftercare. Complimentary skincare routine advice is part of the clinic’s approach.
Our directory also includes VOLNEWMER (EVERESSE) radiofrequency and Ultraformer MPT (HIFU). These are separate CLASSYS technologies, not Merz brands. Exploring the actual device and treatment category helps you compare like for like. Your doctor can explain the different roles of ultrasound, radiofrequency and injectable collagen support without turning your consultation into a list of procedures.
Merz Aesthetics lists Radiesse and Ultherapy in its official product portfolio. That global company page links to US product information; our clinic consultation explains the treatment offered here in London and the guidance relevant to your appointment.
No. Radiesse is an injectable product and Ultherapy is an ultrasound device. They address different aspects of a treatment plan. The appropriate choice starts with your concern and assessment.
No. This guide focuses on Radiesse and Ultherapy, which appear in our treatment directory. A wider company portfolio should not be read as the clinic’s availability list.
Use the dedicated Radiesse and Ultherapy treatment pages or our full price list. We keep the treatment options there so you can see the relevant coverage and booking route together.
Explore Radiesse treatment and prices, read about Ultherapy, or compare the full face and skin treatment directory.
Book a free consultationSearch the treatment library →London Finsbury Clinic · 104 Judd Street, London WC1H 8BU · Company portfolio reviewed 7 November 2026.